drugset / Trial / NCT05639686

TIVA vs TXA in Sinus Surgery to Evaluate Operative Blood Loss and Surgical Field Quality

NCT05639686

RandomizedParallel-groupDouble-blindPrevention

Summary

The goal of this interventional study is to compare the efficacy (surgical field quality and intra-operative blood loss) or cost of TIVA alone to general inhalational anesthetics with intravenous TXA in patient participants who are undergoing endoscopic sinus surgery. The main questions the study aims to answer are: * Is the surgical field quality better when using TIVA alone compared to general inhalational anesthetics with intravenous TXA? * Is one method more financially advantageous to the participant and the institution compared to the other method? Participants will be randomized into one of the two anesthesia cohorts prior to sinus surgery. One group will be given total intravenous anesthesia (TIVA) alone and the other will be given intravenous tranexamic acid (TXA) followed by general inhalational anesthesia. Researchers will compare the TIVA group to the TXA group to see if one group exhibits a better surgery field viewing quality through a subjective evaluation and measurement of blood loss and also which anesthesia regimen is most cost effective upon conducting a cost analysis.

Timeline

Start
2023-01-01
Primary completion
2024-12-31
Completion
2025-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Isoflurane Other / unclassified
Subject Sevoflurane Other / unclassified Inhaled
Subject Tranexamic Acid Small molecule 15 mg/kg Intravenous
Comparator Propofol Small molecule 150 mg/kg
Comparator Remifentanil Small molecule